Given that Patl2 knockdown led to decreased protein levels of multiple cell cycle-related proteins, we suggest that microinjection of CDC23 cRNAs alone would be insufficient to rescue the OMD phenotype induced by PATL2 depletion or mutation. The gene discussed is PATL2; the disease is occult macular dystrophy.